Catalin Toma

Jupiter Endovascular Inc., a medical technology company developing a new class of endovascular interventions based on its proprietary Transforming Fixation (TFX) technology, has appointed interventional cardiologist Catalin Toma, MD, as Chief Medical Officer.

Dr. Toma brings extensive clinical and research experience across the structural heart and interventional landscape. 

He serves concurrently as Director of Interventional Cardiology for the UPMC Heart and Vascular Institute, is an Associate Professor of Medicine at the University of Pittsburgh School of Medicine, and leads the Chronic Total Occlusion Program at UPMC Presbyterian Hospital.

Chief Executive Officer Carl J. St. Bernard described him as a globally recognized physician, researcher and leader in interventional cardiovascular medicine. 

Dr. Toma noted that the company is addressing a long-standing challenge in cardiovascular intervention, balancing catheter flexibility and stability without creating cardiac distress in unstable patients, and pointed to the Vertex System's ability to move between flexible and fixed states.